资料来源：指南以及医学期刊
肺腺癌的转移与首发症状的联系
ASCO: Molecular Testing for All LungAdenocarcinomasASCO：对肺腺癌患者的分子评估Nick MulcahyOctober 13, 2014A guidelinan Society of Clinical Oncology (ASCO) and published online today in theJournal of Clinical Oncology.ASCO最近认可了一项指南，该指南中确定了哪些肺癌患者需要进行分子学测试评估，指南发表在临床肿瘤学杂志10月13日的在线期刊上。Most notably, the guideline states that allpatients with lung adenocarcinoma (or mixed lung cancers with an adenocarcinomacomponent) should undergo testing for epidermal growth factor receptor (EGFR)an ...